Welcome to our dedicated page for UNITEDHEALTH GROUP SEC filings (Ticker: UNH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on UNITEDHEALTH GROUP's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into UNITEDHEALTH GROUP's regulatory disclosures and financial reporting.
Noseworthy John H reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director John H. Noseworthy received 41 shares of Common Stock as a grant tied to dividend equivalents on vested deferred stock units. These additional shares were issued at no cost and bring his directly held position to 7,410 shares.
GARCIA PAUL R reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Paul R. Garcia reported a small equity-related compensation change. He received 13 shares of common stock on June 23, 2026 as a grant or award tied to dividend equivalents on vested deferred stock units, bringing his direct holdings to 3,686 shares of common stock.
In addition, he reported indirect holdings of 55 shares held by Trust 3, 45 shares held by Trust 2, and 2,146 shares held by a revocable trust. The new 13-share award is immediately vested and follows the same terms as the underlying deferred stock units, indicating a routine, compensation-related adjustment rather than an open‑market trade.
MONTGOMERY RICE VALERIE MD reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director receives additional stock-linked units through dividends. Director Valerie Montgomery Rice was granted 41 shares of Common Stock on June 23, 2026 at a stated price of $0.00 per share. These represent dividend equivalents paid on vested deferred stock units and are immediately vested under the same terms as the underlying units. Following this compensation-related award, she directly holds 7,656 shares of UnitedHealth Group common stock, indicating a routine, small-scale adjustment to her equity-based holdings rather than an open-market transaction.
UNITEDHEALTH GROUP INC director Kristen Gil reported a small equity-related update tied to existing awards. On June 23, 2026, Gil acquired 8 shares of Common Stock as a grant or award, recorded at $0.00 per share. A footnote explains these represent dividend equivalents paid on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units. After this acquisition, Gil directly holds 2,411 shares of UnitedHealth Group common stock and also has an indirect holding of 3,800 shares held by a trust.
UNITEDHEALTH GROUP INC director Scott Gottlieb reported a small share award. On the reported date, he acquired 3 shares of common stock at no cost as a grant of dividend equivalents on vested deferred stock units, bringing his direct holdings to 449 shares.
UNITEDHEALTH GROUP INC executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported an automatic share-based compensation adjustment. He acquired 82.488 shares of common stock at a stated price of $0.00 per share as a grant or award.
According to the footnote, these shares represent dividend equivalents paid on outstanding restricted stock units and are subject to the same vesting conditions as those units, meaning they can be forfeited if vesting is not achieved. Following this grant, Conway directly holds 16,996.797 shares of UnitedHealth common stock.
UNITEDHEALTH GROUP INC executive Noel Timothy John, Chief Executive Officer of UnitedHealthcare (UHC), reported an acquisition of 76.063 shares of common stock. These represent dividend equivalents paid on outstanding restricted stock units and carry the same vesting conditions as the underlying units. After this award, his directly held common stock position reported in this filing is 17,650.716 shares. The transaction reflects compensation-related accruals rather than an open‑market purchase.
Zaetta Christopher R reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC EVP & Chief Legal Officer Christopher R. Zaetta received 60.691 shares of common stock as a grant of dividend equivalents tied to existing restricted stock units. The award carried no purchase price and increased his directly held common stock to 15,859.84 shares.
The dividend equivalents will vest or be forfeited under the same terms as the underlying restricted stock units. A separate June 8, 2026 transfer of shares and options was exempt from Section 16 reporting under applicable SEC rules.
DeVeydt Wayne S reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC Chief Financial Officer Wayne S. DeVeydt reported receiving a grant of 111.76 shares of common stock on June 23, 2026. The award reflects dividend equivalents paid on his outstanding restricted stock units and carries a grant price of $0.00 per share.
The dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest. Following this compensation-related award, DeVeydt directly holds 19,778.69 shares of UnitedHealth Group common stock.
HEMSLEY STEPHEN J reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director and CEO Stephen J. Hemsley reported routine equity updates. He received 46 shares of Common Stock as dividend equivalents on vested deferred stock units at $0.00 per share, raising his direct holdings to 48,098.942 shares.
Indirect holdings now include 1,006,831 shares by trusts and 356.8592 shares via a 401(k). Footnotes state that earlier large-share movements between his direct holdings and trusts were exempt transfers under Section 16 rules, reflecting internal reallocations rather than market trades.